Bittner F, Murchison C, Koop D, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Sep; 4(5): e380.

Peak serum levels of alpha lipoic acid did not significantly change after one year of alpha lipoic acid (1,200 mg/daily) administration, in secondary progressive MS patients.